Japan Medical Supplies Suppliers

Hitachi, Ltd.

Tokyo

Hitachi was founded in 1910 by engineer Namihei Odaira, who built a 5-horsepower motor — Japan's first domestically produced electric motor — after studying at the Hitachi copper mine, which gave the company its name. The motor succeeded, and Hitachi grew into Japan's biggest industrial conglomerate, a sprawling group of hundreds of companies making everything from trains to hard drives to nuclear reactors. Today Hitachi has consolidated around 'social innovation': digital systems & services (IT infrastructure, Lumada IoT platforms, and financial services software), green energy & mobility (high-speed trains — its bullet trains run on Japan's Shinkansen and were exported to Britain and Taiwan — plus grid equipment and EV components), and connected industries (industrial automation, elevators — the world's largest elevator maker — and building systems). Its global logic division makes the hard disk drives inside data centers, and Hitachi Construction Machinery builds excavators. With about 270,000 employees and annual revenue near ¥9.7 trillion (US$65 billion), Hitachi has sold its semiconductor, battery, and metals businesses to become a digital-and-infrastructure champion. Its Lumada platform — combining operational technology with IT — is the company's answer to Industry 4.0, connecting the physical infrastructure of cities and factories to cloud analytics. For governments and utilities, Hitachi is the Japanese conglomerate that builds the systems society runs on.

Otsuka Pharmaceutical Co., Ltd. is a Japanese holistic healthcare company operating two core businesses: pharmaceuticals for diagnosis and treatment of diseases, and nutraceuticals including nutritional products and cosmedics. It develops and manufactures prescription drugs, consumer health products, and functional foods such as POCARI SWEAT and SOYJOY. The company is headquartered in Japan and is part of Otsuka Holdings.

TOWA PHARMACEUTICAL CO.,LTD. is a Japanese pharmaceutical manufacturer specializing in generic drugs and formulation development. The company operates its own manufacturing sites for active pharmaceutical ingredients (API) and finished formulations, ensuring stable supply. It is listed on the Tokyo Stock Exchange and provides drug information sheets for its product lineup.